WeChat Mini Program
Old Version Features

Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: an Open-Label, Phase 1 Study

Aung Naing,Amit Mahipal,Milind Javle,Judy Wang,Todd M Bauer,David L Bajor,Anthony D Elias,Anthony Shields,Elizabeth Davis,Sant Chawla,Howard Safran,John D Powderly, Gina D'Amato, Christian F Meyer, Xiongwen Tang,Sheng Yao,Patricia Keegan

Journal of immunotherapy and precision oncology（2025）

Cited 0|Views2
Key words
immune checkpoint inhibitor,programmed cell death (pd-1),refractory cholangiocarcinoma,safety,anti-tumor activity
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined